Bögemann M - Search Results

1

[Use of the S3 guidelines for early detection of prostate cancer in urological practices].

Tiedje D, Quer O, Breil B, Schrader AJ, Bothe C, Kruse K, Bögemann M, Donner-Banzhoff N, Semjonow A. Tiedje D, et al. Among authors: bogemann m. Urologe A. 2017 Jul;56(7):910-916. doi: 10.1007/s00120-017-0352-1. Urologe A. 2017. PMID: 28280863 German.

2

Safety and Efficacy of Extended Therapy with [¹⁷⁷Lu]Lu-PSMA: A German Multicenter Study.

Seifert R, Telli T, Lapa C, Desaulniers M, Hekimsoy T, Weber WA, Pfob C, Hadaschik B, Bögemann M, Schäfers M, Herrmann K, Rahbar K, Eiber M, Fendler WP. Seifert R, et al. Among authors: bogemann m. J Nucl Med. 2024 Jun 3;65(6):909-916. doi: 10.2967/jnumed.123.267321. J Nucl Med. 2024. PMID: 38697669

3

The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape.

Doehn C, Bögemann M, Grünwald V, Welslau M, Bedke J, Schostak M, Wolf T, Ehneß R, Degenkolbe E, Witecy S, Goebell PJ. Doehn C, et al. Among authors: bogemann m. Cancers (Basel). 2022 Nov 8;14(22):5486. doi: 10.3390/cancers14225486. Cancers (Basel). 2022. PMID: 36428579 Free PMC article.

4

Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial.

Hussain M, Tombal B, Saad F, Fizazi K, Sternberg CN, Crawford ED, Shore N, Kopyltsov E, Kalebasty AR, Bögemann M, Ye D, Cruz F, Suzuki H, Kapur S, Srinivasan S, Verholen F, Kuss I, Joensuu H, Smith MR. Hussain M, et al. Among authors: bogemann m. J Clin Oncol. 2023 Jul 10;41(20):3595-3607. doi: 10.1200/JCO.23.00041. Epub 2023 Feb 16. J Clin Oncol. 2023. PMID: 36795843 Clinical Trial.

5

Time after Synthesis and Time after Injection Do Not Affect Diagnostic Quality of [¹⁸F]F-PSMA 1007 PET.

Relt E, Roll W, Claesener M, Bögemann M, Weckesser M, Rahbar K. Relt E, et al. Among authors: bogemann m. Cancers (Basel). 2022 Oct 20;14(20):5141. doi: 10.3390/cancers14205141. Cancers (Basel). 2022. PMID: 36291925 Free PMC article.

6

Erratum to "Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial" [Eur Urol 2022].

Bögemann M, Shore ND, Smith MR, Tammela TLJ, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Lebret T, Schostak M, Verholen F, Le Berre MA, Srinivasan S, Ortiz J, Mohamed AF, Sarapohja T, Fizazi K. Bögemann M, et al. Eur Urol. 2023 Feb;83(2):e60. doi: 10.1016/j.eururo.2022.11.018. Epub 2022 Dec 14. Eur Urol. 2023. PMID: 36526492 Free article. No abstract available.

7

Role of apalutamide in the treatment landscape for patients with advanced prostate cancer: an expert opinion statement of European clinical practice.

Bögemann M, Facchini G, Bauernhofer T, Cathomas R, Xylinas E, Tombal B. Bögemann M, et al. Ir J Med Sci. 2023 Dec;192(6):2643-2651. doi: 10.1007/s11845-023-03303-y. Epub 2023 Mar 22. Ir J Med Sci. 2023. PMID: 36944842 Free PMC article.

8

Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer.

Stephan C, Jung K, Semjonow A, Schulze-Forster K, Cammann H, Hu X, Meyer HA, Bögemann M, Miller K, Friedersdorff F. Stephan C, et al. Among authors: bogemann m. Clin Chem. 2013 Jan;59(1):280-8. doi: 10.1373/clinchem.2012.195560. Epub 2012 Dec 4. Clin Chem. 2013. PMID: 23213079

9

[Systemic treatment of metastatic renal cell carcinoma: change of paradigms after introduction of targeted therapy].

Papavassilis P, Krabbe LM, Thielen B, Bögemann M, Moritz R, Hoffmeister I, Hertle L, Herrmann E. Papavassilis P, et al. Among authors: bogemann m. Urologe A. 2014 Apr;53(4):531-6. doi: 10.1007/s00120-013-3408-x. Urologe A. 2014. PMID: 24549799 German.

10

Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those detected on the initial biopsies.

Eminaga O, Hinkelammert R, Abbas M, Titze U, Eltze E, Bettendorf O, Wötzel F, Bögemann M, Semjonow A. Eminaga O, et al. Among authors: bogemann m. BJU Int. 2015 Jul;116(1):57-64. doi: 10.1111/bju.12691. Epub 2015 Apr 17. BJU Int. 2015. PMID: 24552505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters